47 forecasters

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

83%chance

Forecast Timeline

No key factors yetAdd some that might influence this forecast.

Add key factor

Authors:

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Spot Scoring Time:

Nov 26, 2021

Health & Pandemics

Are you ‘Ozempic sober’? GLP-1s are making users feel less drunk

New York Post•Oct 15, 2025

In this state, obesity is a major problem. But a new GLP-1 benefit is failing to catch on.

USA Today•Oct 13, 2025

My Ozempic is causing the most disgusting side effect and it's really getting to me... I don't know what to do'

Daily Mail•Oct 13, 2025

Learn more about Metaculus NewsMatch